Anxiety disorder observation study
Part of Mental health clinical trials.
This study observes people with generalized anxiety disorder to learn more about the condition. It may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with generalized anxiety disorder by a doctor
- You are between 18 and 65 years old
- You have at least a junior high school education
- You are able to fill out questionnaires
- You do not have other psychiatric conditions or serious medical issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.
This study tests a psilocybin oral solution in adults with generalized anxiety disorder (GAD). It aims to see if the drug is safe, tolerable, and helpful for reducing anxiety symptoms.
This study tests whether adding a gentle brain stimulation technique (transcranial alternating current stimulation) to mindfulness therapy can help reduce anxiety symptoms in people with generalized anxiety disorder. It aims to see if this combination is more effective than mindfulness alone.
This study tests a gentle brain stimulation method called High-Definition Transcranial Electrical Stimulation (HD-tES) to see if it can help reduce anxiety symptoms in people with Generalized Anxiety Disorder. It uses small electrodes on the scalp to deliver mild electrical currents to areas of the brain involved in anxiety, without surgery or major side effects.
This trial tests an oral medicine called ABBV-932 when added to current antidepressant therapy for people with generalized anxiety disorder (GAD) who still have symptoms. It aims to see if the combination can improve anxiety and reduce side effects.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
Hear when a new Generalized Anxiety Disorder (GAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.